Quinazoline Derivative kzl052 Suppresses Prostate Cancer by Targeting WRN Helicase to Stabilize DNA Replication Forks
Open Access
- 25 June 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (13) , 6093
Abstract
WRN helicases play a key role in DNA replication, repair, and other processes in a variety of tumors. It has become one of the hot targets of genotoxic drugs, but the effect and mechanism of targeting WRN against prostate cancer is still unclear. In our previous study, we found a quinazoline compound kzl052, which has a WRN-dependent inhibitory effect on prostate cancer cells, but its molecular mechanism needs to be further explored. In this study, kzl052 significantly inhibited the growth of PC3 (IC50 = 0.39 ± 0.01 μM) and LNCaP (IC50 = 0.11 ± 0.01 μM) cells in vitro and showed a good inhibition effect on PCa in vivo. It inhibits PC3 cell growth by binding to WRN proteins and affecting its non-enzymatic function. Then the mechanism of kzl052 against prostate cancer progression was revealed to be by regulating the stability of DNA replication forks and the RB pathway. This study will provide a theoretical basis and treatment strategy for targeting WRN helicase in the treatment of prostate cancer.Keywords
Funding Information
- Guizhou Provincial Major Scientific and Technological Program ([2024]015, QKHPTRC-GCC[2022]034-1, QKHJC-ZK[2022]ZD031, QKHJC-ZK[2023]YB241, 82273818, 22NSFCP24, 2024GZYXKYJJXM0095)
- Department of Science and Technology of Guizhou Province ([2024]015, QKHPTRC-GCC[2022]034-1, QKHJC-ZK[2022]ZD031, QKHJC-ZK[2023]YB241, 82273818, 22NSFCP24, 2024GZYXKYJJXM0095)
- National Natural Science Foundation of China ([2024]015, QKHPTRC-GCC[2022]034-1, QKHJC-ZK[2022]ZD031, QKHJC-ZK[2023]YB241, 82273818, 22NSFCP24, 2024GZYXKYJJXM0095)
- National Fund Cultivation Project of Guizhou Medical University ([2024]015, QKHPTRC-GCC[2022]034-1, QKHJC-ZK[2022]ZD031, QKHJC-ZK[2023]YB241, 82273818, 22NSFCP24, 2024GZYXKYJJXM0095)
- Medical Research Union Found for High-quality health development of Guizhou Province ([2024]015, QKHPTRC-GCC[2022]034-1, QKHJC-ZK[2022]ZD031, QKHJC-ZK[2023]YB241, 82273818, 22NSFCP24, 2024GZYXKYJJXM0095)
This publication has 44 references indexed in Scilit:
- Discovery of novel quinazoline derivatives containing trifluoromethyl against cell proliferation by targeting werner helicaseMolecular Diversity, 2025
- Elucidating acquired PARP inhibitor resistance in advanced prostate cancerCancer Cell, 2024
- Quinazoline derivatives inhibit cell growth of prostate cancer as a WRN helicase dependent manner by regulating DNA damage repair and microsatellite instabilityBioorganic Chemistry, 2024
- PARP1-DNA co-condensation drives DNA repair site assembly to prevent disjunction of broken DNA endsCell, 2024
- The enigma of race and prostate cancerCancer, 2023
- Inhibition of FEN1 promotes DNA damage and enhances chemotherapeutic response in prostate cancer cellsMedical Oncology, 2023
- WRN rescues replication forks compromised by a BRCA2 deficiency: Predictions for how inhibition of a helicase that suppresses premature aging tilts the balance to fork demise and chromosomal instability in cancerBioEssays, 2022
- Resistance to DNA repair inhibitors in cancerMolecular Oncology, 2022
- Werner Syndrome Protein Expression in Breast CancerClinical Breast Cancer, 2021
- Mutations in conserved functional domains of human RecQ helicases are associated with diseases and cancer: A reviewBiophysical Chemistry, 2020